Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96783083 | 9678308 | 3 | F | 2013 | 20160727 | 20131108 | 20160810 | EXP | BR-PFIZER INC-2013195371 | PFIZER | 59.00 | YR | M | Y | 79.00000 | KG | 20160810 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96783083 | 9678308 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | Oral | 37.5 MG (25 MG + 12.5 MG), CYCLIC (3 X 1) | U300A | 21938 | 37.5 | MG | CAPSULE, HARD | ||||||
| 96783083 | 9678308 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | UNK | N492B | 21938 | CAPSULE, HARD | |||||||||
| 96783083 | 9678308 | 3 | SS | SUTENT | SUNITINIB MALATE | 1 | UNK | U644A | 21938 | CAPSULE, HARD | |||||||||
| 96783083 | 9678308 | 4 | SS | SUTENT | SUNITINIB MALATE | 1 | 37.5 MG CYCLE 2/1 | 21938 | 37.5 | MG | CAPSULE, HARD | ||||||||
| 96783083 | 9678308 | 5 | C | LOSARTAN. | LOSARTAN | 1 | UNK | 0 | |||||||||||
| 96783083 | 9678308 | 6 | C | CLONAZEPAM. | CLONAZEPAM | 1 | STRENGTH 0.25MG | 0 | |||||||||||
| 96783083 | 9678308 | 7 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | STRENGTH 20MG | 0 | |||||||||||
| 96783083 | 9678308 | 8 | C | PURAN | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 96783083 | 9678308 | 9 | C | ATORVASTATIN | ATORVASTATIN | 1 | 0 | ||||||||||||
| 96783083 | 9678308 | 10 | C | NORTRIPTYLINE | NORTRIPTYLINE | 1 | STRENGTH 25MG | 0 | |||||||||||
| 96783083 | 9678308 | 11 | C | CONCOR | BISOPROLOL FUMARATE | 1 | STRENGTH 2.5MG | 0 | |||||||||||
| 96783083 | 9678308 | 12 | C | SIMVASTATIN. | SIMVASTATIN | 1 | STRENGTH 20 MG | 0 | |||||||||||
| 96783083 | 9678308 | 13 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | STRENGTH 5MG | 0 | |||||||||||
| 96783083 | 9678308 | 14 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | STRENGTH 100MG | 0 | |||||||||||
| 96783083 | 9678308 | 15 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | STRENGTH 100MG | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 96783083 | 9678308 | 1 | Metastatic renal cell carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 96783083 | 9678308 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 96783083 | 9678308 | Bone pain | |
| 96783083 | 9678308 | Dyschezia | |
| 96783083 | 9678308 | Dysuria | |
| 96783083 | 9678308 | Fatigue | |
| 96783083 | 9678308 | Haemorrhage | |
| 96783083 | 9678308 | Nail discolouration | |
| 96783083 | 9678308 | Penile swelling | |
| 96783083 | 9678308 | Penis disorder | |
| 96783083 | 9678308 | Skin sensitisation | |
| 96783083 | 9678308 | Swelling face | |
| 96783083 | 9678308 | Thermal burn | |
| 96783083 | 9678308 | Yellow skin |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 96783083 | 9678308 | 1 | 20130530 | 0 |